• No results found

[PDF] Top 20 Innovation by patients with rare diseases and chronic needs

Has 10000 "Innovation by patients with rare diseases and chronic needs" found on our website. Below are the top 20 most common "Innovation by patients with rare diseases and chronic needs".

Innovation by patients with rare diseases and chronic needs

Innovation by patients with rare diseases and chronic needs

... the innovation and after the respondent used the solution; the quality of life for the two time periods was measured on a 7-point scale, from 1 – extremely low, to 7 – ... See full document

9

Public and patient involvement in needs assessment and social innovation: a people centred approach to care and research for congenital disorders of glycosylation

Public and patient involvement in needs assessment and social innovation: a people centred approach to care and research for congenital disorders of glycosylation

... the needs of people affected by CDG and to elicit innovative strategies to address them using a think tank methodology that engaged stakeholders from twenty countries across the ...unmet needs: infor- ... See full document

11

Funding innovation for treatment for rare diseases: adopting a cost-based yardstick approach

Funding innovation for treatment for rare diseases: adopting a cost-based yardstick approach

... 200 patients using the product in the UK, that would suggest that the price per patient should allow for the assessed production and distribution costs, plus an additional $40,000 to pay for the pro rata R&D ... See full document

9

Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen

Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen

... In the EU, alternatively to the prevalence of the condi- tion, the second criteria to designate an OMP considers the lack of sufficient return generated from the marketing of the medicinal product intended for a ... See full document

11

Review of 11 national policies for rare diseases in the context of key patient needs

Review of 11 national policies for rare diseases in the context of key patient needs

... for rare diseases is commensurate with overall GDP as well as investment in innovation, science, and healthcare; it has been relatively well funded with gov- ernment investment in some countries ... See full document

13

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

Telephone health services in the field of rare diseases: a qualitative interview study examining the needs of patients, relatives, and health care professionals in Germany

... enable patients, relatives, and HCPs to access information rapidly, this study shows that there is still a point in making information accessible the ‘old-fashioned way’ via ...all patients, relatives, and ... See full document

14

Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases

Key outcomes from stakeholder workshops at a symposium to inform the development of an Australian national plan for rare diseases

... for patients, carers and ...individualized needs-driven focus (not a disease focus); emphasize flexibility, integration, cost effectiveness and cost efficiencies for the health system; and be founded on ... See full document

10

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases

Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases

... with rare diseases when no other treatment is ...to patients due to lack of interest from the pharmaceutical industry to apply for market authorization as ... See full document

9

<p>Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity</p>

<p>Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity</p>

... MPN, patients with ET or PV generally experienced higher rates of both arterial and venous vascular diseases, than members of the comparison cohorts (Figures 1 and ...in patients with ...among ... See full document

13

Characteristics of patients contacting a center for undiagnosed and rare diseases

Characteristics of patients contacting a center for undiagnosed and rare diseases

... Undiagnosed Diseases Program (UDP), supported by the Office of Rare Diseases Re- search, the National Human Genome Research Institute (NHGRI), and the NIH Clinical Center, was established to diagnose ... See full document

9

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

... on rare diseases during medical school and continuous medical ...about rare diseases. Extensive knowledge on rare diseases cannot be expected from medical students, but they ... See full document

11

Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study

Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study

... every rare disease is rare. However, together rare diseases are ...a rare disease in their lifetime [2]. Rare dis- ease diagnosis remains a challenge for patients, ... See full document

12

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases

Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases

... a rare disease. Currently, international definitions of rare diseases vary ...considered rare if it affects fewer than one in 2000 citizens, whereas in the United States a disease is ... See full document

11

Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire

Spiritual needs of patients with chronic pain diseases and cancer - validation of the spiritual needs questionnaire

... existential needs of patients dealing with chronic ...Europe´s patients with chronic diseases several do not regard themselves as religious (despite of an alleged Christian ... See full document

8

Compounded medication for patients with rare diseases

Compounded medication for patients with rare diseases

... patient needs that do not have a licensed (commercial) medicine available on the ...with rare diseases have individual needs that may benefit from sterile and non-sterile compounded medi- ... See full document

8

Sarcoidosis with involvement of the paranasal sinuses - a retrospective analysis of 12 biopsy-proven cases

Sarcoidosis with involvement of the paranasal sinuses - a retrospective analysis of 12 biopsy-proven cases

... in patients with sarcoidosis. We found 12 patients out of 1360 pa- tients with sarcoidosis to have biopsy proven sinonasal ...of patients being affected by sinonasal involvement is in line with the ... See full document

5

A study of medication use within insured patients with chronic diseases

A study of medication use within insured patients with chronic diseases

... In Brazil study, the highest prevalence of low adherence to treatment was found among individuals who had to pay part of their treatment compared to those who had free access to all medicines needed to treat reported ... See full document

9

The OPTIMAL study: A randomized controlled trial and process evaluation of an occupational therapy led self management support programme for people with multimorbidity in primary care

The OPTIMAL study: A randomized controlled trial and process evaluation of an occupational therapy led self management support programme for people with multimorbidity in primary care

... 35 and advocates for continuity and a coordinated approach to care (National Institute for Clinical Excellence, 2016). The quality of care which individuals with multimorbidity receive has been examined with some ... See full document

444

Bilateral simultaneous complete quadriceps rupture following chronic symptomatic tendinopathy: a case report

Bilateral simultaneous complete quadriceps rupture following chronic symptomatic tendinopathy: a case report

... Introduction: Quadriceps rupture is a disabling injury mostly seen in men over 40 years of age. Bilateral quadriceps rupture is a rare injury that is often secondary to predisposing medical conditions. Ultrasound ... See full document

5

Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases

Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases

... composition. Patients with CB and COPD have shown an accumulation of 20:4n-6 against a deficiency of ...in patients with COPD is more pronounced than in patients with ... See full document

6

Show all 10000 documents...